Here's a piece on scengen. not the one i found the other day though. It just looks so suspect. Reminds me of pharmaceuticals and what they are capable of.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China
ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024
TIG Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead
